Table 1. Patient Characteristics at Baseline in All Patients and the ACS and SAP Groups.
| All patients | ACS | SAP | |
|---|---|---|---|
| No. of patients | 176 | 50 | 126 |
| Age, years | 69 ± 11 | 68 ± 11 | 70 ± 11 |
| Male, n (%) | 143 (81) | 43 (86) | 100 (79) |
| BMI, kg/m2 | 24.0 ± 3.5 | 24.2 ± 3.5 | 24.0 ± 3.5 |
| Smoking, % | 106 (60) | 30 (60) | 76 (60) |
| Prior MI, n (%) | 40 (23) | 9 (18) | 31 (25) |
| Prior PCI, n (%) | 65 (37) | 12 (24)* | 53 (42) |
| Prior CABG, n (%) | 13 (7) | 5 (10) | 8 (6) |
| SBP, mm Hg | 130 ± 19 | 128 ± 22 | 131 ± 16 |
| DBP, mm Hg | 73 ± 14 | 76 ± 16 | 72 ± 13 |
| DL, % | 163 (93) | 48 (96) | 115 (91) |
| TG, mg/dL | 133 ± 85 | 121 ± 74 | 138 ± 89 |
| LDL-C, mg/dL | 99 ± 31 | 103 ± 34 | 97 ± 30 |
| HDL-C, mg/dL | 46 ± 12 | 45 ± 11 | 47 ± 12 |
| DM, % | 69 (39) | 17 (34) | 52 (41) |
| HbA1c, % | 6.3 ± 1.2 | 6.2 ± 1.3 | 6.3 ± 1.2 |
| LVEF, % | 60 ± 15 | 54 ± 16* | 62 ± 14 |
| eGFR | 61 ± 21 | 65 ± 24 | 59 ± 20 |
| Medications | |||
| ARB/ACE-I | 147 (84) | 44 (88) | 103 (82) |
| CCB | 131 (74) | 32 (64)* | 99 (79) |
| β-blocker | 66 (38) | 27 (54)** | 39 (31) |
| Diuretics | 34 (19) | 12 (24) | 22 (17) |
| Statin | 155 (88) | 45 (90) | 110 (87) |
| Nitrate | 118 (67) | 28 (56)* | 90 (78) |
| Nicorandil | 30 (17) | 9 (18) | 21 (17) |
| OHA | 43 (24) | 13 (26) | 30 (24) |
| Insulin | 7 (4) | 2 (4) | 5 (4) |
| Target vessels of PCI | |||
| RCA/LAD/LCx/LMT/BG, n (%) | 59/84/27/2/4 (34/48/15/1/2) | 14/26/6/1/3 (28/58/12/6/2) | 45/58/21/1/1 (36/46/17/1/1) |
| PCI procedure | |||
| BMS/DES/POBA, n (%) | 42/123/11 (24/70/6) | 23/24/3 (46/48/6)* | 19/99/8 (15/79/6) |
| Stent length of BMS or DES | 22.0 ± 6.9 | 22.4 ± 5.8 | 21.9 ± 7.2 |
| Stent size of BMS or DES | 3.1 ± 0.4 | 3.2 ± 0.4* | 3.0 ± 0.4 |
SAP: stable angina pectoris; ACS: acute coronary syndrome; BMI: body mass index; MI: myocardial infarction; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; SBP: systolic blood pressure; DBP: diastolic blood pressure; DL: dyslipidemia; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; DM: diabetes mellitus; HbA1c: hemoglobin A1c; LVEF: left ventricular ejection fraction; eGFR: estimated glomerular filtration rate; ARB: angiotensin II receptor blocker; ACE-I: angiotensin converting enzyme inhibitor; CCB: calcium channel blocker; OHA: oral hypoglycemic agent; RCA: right coronary artery; LAD: left anterior descending coronary artery; LCx: left circumflex coronary artery; LMT: left main trunk; BG: bypass graft; BMS: bare-metal stent; DES: drug-eluting stent; POBA: plain old balloon angioplasty. *P < 0.05, **P < 0.01 vs. SAP group.